An improved PDE6D inhibitor combines with Sildenafil to synergistically inhibit KRAS mutant cancer cell growth
Pelin Kaya(University of Luxembourg), Daniel Abankwa(Åbo Akademi University)
Cited by 0
Related Papers
Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation
|eLife|2015|50
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling
|Molecular and Cellular Biology|2016|25
Rapalogs can promote cancer cell stemness <i>in vitro</i> in a Galectin-1 and H-ras-dependent manner
|Oncotarget|2017|23
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell Growth
|Journal of Medicinal Chemistry|2024|23